Ji‐Min Zhu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
- Molecular Biology top 10%
- RNA modifications and cancer 10
- RNA Research and Splicing 8
- Circular RNAs in diseases 6
- Glycosylation and Glycoproteins Research 4
- Hepatology top 10%
- Oncology top 10%
-
- Immune cells in cancer 5
-
- Nanoplatforms for cancer theranostics 6
- Co-authors
- Xizhong ShenTaotao LiuLing DongShu‐Qiang WengXiang‐Nan YuGuangcong ZhangGuangqi SongDanying Zhang
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ji‐Min Zhu
58 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 562
- Molecular Biology 1.0k
- Hepatology 83
- Oncology 262
- Immunology 173
Countries citing papers authored by Ji‐Min Zhu
This map shows the geographic impact of Ji‐Min Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Min Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Min Zhu more than expected).
Fields of papers citing papers by Ji‐Min Zhu
This network shows the impact of papers produced by Ji‐Min Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Min Zhu. The network helps show where Ji‐Min Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ji‐Min Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 20 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 36 | |
| 14 | 2021 | 13 | |
| 15 | 2021 | 9 | |
| 16 | 2020 | 41 | |
| 17 | 2020 | 11 | |
| 18 | 2019 | 33 | |
| 19 | 2019 | 6 | |
| 20 | 2019 | 5 |
About Ji‐Min Zhu
Ji‐Min Zhu is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 58 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (10 papers), MicroRNA in disease regulation (8 papers), RNA Research and Splicing (8 papers), Nanoplatforms for cancer theranostics (6 papers), Circular RNAs in diseases (6 papers), Immune cells in cancer (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Cancer Research (562 citations), Molecular Biology (1.0k citations) and Hepatology (83 citations). Ji‐Min Zhu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xizhong Shen, Taotao Liu, Ling Dong, Shu‐Qiang Weng, Xiang‐Nan Yu, Guangcong Zhang, Guangqi Song, Danying Zhang, Hairong Zhu and Xuan Shi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.